Corrigendum to Endotoxin removal and prevention for pre-clinical biologics production [Biotechnol. J., 7, (2012), 1509-1516] DOI: 10.1002/biot.201200220;Endotoxin removal and prevention for pre-clinical biologics production

Biotechnology Journal

Volumn 7, Issue 12, 2012, Pages 1509-1516

  Serdakowski London, Anne ^a   Kerins, Brendan ^b   Tschantz, William R ^a   Mackay, Kasey ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Chromatography; Endotoxin; Pre Clinical; Protein production; Purification

Indexed keywords

CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; PURIFICATION;

BIOLOGICS PRODUCTION; CHROMATOGRAPHIC SEPARATIONS; ENDOTOXIN; GOOD MANUFACTURING PRACTICES; PRE-CLINICAL; PROTEIN PRODUCTION; RECOMBINANT PROTEIN PRODUCTIONS; TRANSIENT TRANSFECTION;

RECOMBINANT PROTEINS;

BACTERIAL DNA; BIOLOGICAL PRODUCT; ENDOTOXIN; RESIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; CLINICAL PROTOCOL; DRUG DETOXIFICATION; GEL FILTRATION CHROMATOGRAPHY; GOOD MANUFACTURING PRACTICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; HYDROPHOBICITY; MEMBRANE FILTER; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PURIFICATION; TRANSIENT TRANSFECTION;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 84870677058     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201390040     Document Type: Erratum

References (31)

1. European Directorate for the Quality of Medicines, European Pharmacopoeia, 3rd edn. Council of Europe, Strasbourg 1997.
2. Galanos, C., Freudenberg, M. A., Bacterial endotoxins: Biological properties and mechanisms of action. Mediators Inflamm. 1993, 2, S11-S16.
3. Malyala, P., Singh, M., Endotoxin limits in formulations for preclinical research. J. Pharm. Sci. 2008, 97, 2041-2044.
4. Raetz, C. R., Ulevitch, R. J., Wright, S. D., Sibley, C. H. et al., Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 1991, 5, 2652-2660.
5. Magalhães, P. O., Lopes, A. M., Mazzola, P. G., Rangel-Yagui, C. et al., Methods of endotoxin removal from biological preparations: A review. J. Pharm. Sci. 2007, 10, 388-404.
6. Walsh, G. (Ed.), Biopharmaceuticals: Biochemistry and Biotechnology, 2nd Edn. John Wiley & Sons, Chichester 2003.
7. Jang, H., Kim, H. S., Moon, S. C., Lee, Y. R. et al., Effects of protein concentration and detergent on endotoxin reduction by ultrafiltration. BMB Rep. 2009, 42, 462-466.
8. Fujita, I., Watanabe, H., Miyamoto, M., Method for removing pertussis endotoxin, a pertussis toxoid and its production. US Patent EP211968, 1988.
9. Mitzner, S., Schneidewind, J., Falkenhagen, D., Loth, F., Klinkmann, H., Extracorporeal endotoxin removal by immobilized polyethylenimine. Artif. Organs 1993, 17, 775-781.
10. Weber, C., Henne, B., Loth, F., Schoenhofen, M., Falkenhagen, D., Development of cationically modified cellulose adsorbants for the removal of endotoxins. ASAIO J. 1995, 41, 430-434.
11. Anspach, F. B., Endotoxin removal by affinity sorbents. J. Biochem. Biophys. Methods 2001, 49, 665-681.
12. Matsumae, H., Minobe, S., Kindan, K., Watanabe, T. et al., Specific removal of endotoxin from protein solutions by immobilized histidine. Biotechnol. Appl. Biochem. 1990, 12, 129-140.
13. Sakata, M., Kawai, T., Ohkuma, K., Ihara, H., Hirayama, C., Reduction of endotoxin contamination of various crude vaccine materials by gram-negative bacteria using aminated poly (gamma-methyl L-glutamate) spherical particles. Biol. Pharm. Bull. 1993, 16, 1065-1068.
14. Aida, Y., Pabst, M. J., Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 1990, 132, 191-195.
15. Liu, S., Tobias, R., McClure, S., Styba, G. et al., Removal of endotoxin from recombinant protein preparations. Clin. Biochem. 1997, 30, 455-463.
16. Ohno, N., Morrison, D. C., Lipopolysaccharide interaction with lysozyme. J. Biol. Chem. 1989, 264, 4434-4441.
17. Kaca, W., Roth, R. I., Levin, J., Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J. Biol. Chem. 1994, 269, 25078-25084.
18. Petsch, D., Anspach, F. B., Endotoxin removal from protein solutions. J. Biotechnol. 2000, 76, 97-119.
19. Shukla, A. A., Hubbard, B., Tressel, T., Guhan, S., Low, D., Downstream processing of monoclonal antibodies - Application of platform approaches. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 848, 28-39.
20. Lute, S., Norling, L., Hanson, M., Emery, R. et al., Robustness of virus removal by protein A chromatography is independent of media lifetime. J. Chromatogr. A 2008, 1205, 17-25.
21. Teeters, M., Benner, T., Bezila, D., Shen, H. et al., Predictive chromatographic simulations for the optimization of recovery and agrgegate clearance during the capture of monoclonal antibodies. J. Chromatogr. A 2009, 1216, 6134-6140.
22. Ishihara, T., Nakajima, N., Kadoya, T., Evaluation of new affinity chromatography resins for polyclonal, oligoclonal, and monoclonal antibody pharmaceuticals. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878, 2141-2144.
23. Gorbet, M. B., Sefton, M. V., Endotoxin: The uninvited guest. Biomaterials 2005, 6811-6817.
24. Ongkudon, C. M., Chew, J. H., Liu, B., Danquah, M. K., Chromatographic removal of endotoxins: A bioprocess engineer's perspective, ISRN Chromatogr. 2012, doi: 10.5402/2012/649746.
25. Page, M., Thorpe, R., Purification of IgG using gel-filtration chromatography, in: The Protein Protocols Handbook, vol. IV. Humana Press, New York 1996, pp. 735-737.
26. Ó'Fágáin, C., Cummins, P. M., O'Connor, B. F., Gel-filtration chromatography, in: Walls, D., Loughran, S.T. (Eds.), Protein Chromatography: Methods and Protocols, Humana Press, New York 2011, pp. 25-33.
27. Fiske, M. J., Fredenburg, R. A., Van Der Meid, K. R., McMichael, J. C., Arumughan, R., Method for reducing endotoxin in Moraxella catarrahalis UspA2 protein preparations. J. Chromatogr. B Biomed. Sci. Appl. 2001, 753, 269-278.
28. Horowitz, B., Bonomo, R., Prince, A.M., Chin, S.N. et al., Solvent/detergent-treated plasma: A virus-inactivated substitute for fresh frozen plasma. Blood 1992, 79, 826-831.
29. Franken, K. L., Hiemstra, H. S., van Meijgaardeb, K. E., Subronto, Y. et al., Purification of his-tagged proteins by immobilized chelate affinity chromatography: The benefits from the use of organic solvent. Protein Express. Purif. 2000, 18, 95-99.
30. Bordier, C., Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 1981, 256, 1604-1607.
31. Ludwig, J. D., Avis, K. E., Dry heat inactivation of endotoxin on the surface of glass. J. Parenter. Sci. Technol. 1990, 44, 4-12.